about
Immunization with recombinant murine cytomegalovirus expressing murine zona pellucida 3 causes permanent infertility in BALB/c mice due to follicle depletion and ovulation failureLeukocyte Populations in Human Preterm and Term Breast Milk Identified by Multicolour Flow Cytometry.Inactivation of Cytomegalovirus in Breast Milk Using Ultraviolet-C Irradiation: Opportunities for a New Treatment Option in Breast Milk Banking.Biological control of vertebrate pests using virally vectored immunocontraception.A retrospective audit of bacterial culture results of donated human milk in Perth, Western Australia.Levels of innate immune factors in preterm and term mothers' breast milk during the 1st month postpartum.Geoff Shellam (1942-2015).Promoter control over foreign antigen expression in a murine cytomegalovirus vaccine vector.Overcoming innate host resistance to vaccination: employing a genetically distinct strain of murine cytomegalovirus avoids vector-mediated resistance to virally vectored immunocontraception.Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice.Assessment of contraceptive vaccines based on recombinant mouse sperm protein PH20.Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3.Viral vectored immunocontraception: screening of multiple fertility antigens using murine cytomegalovirus as a vaccine vector.Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vectorA clinical audit of the growth of preterm infants fed predominantly pasteurised donor human milk v. those fed mother's own milk in the neonatal intensive care unit
P50
Q28589850-FFA29FBD-5665-4DDB-A825-7CFC684FECF0Q35750371-094E32F4-5FBF-4AE5-80AA-9180B02C8A89Q36106868-9DFFF359-1858-4DDF-8CDC-287719BAEDEDQ36547944-EBB88690-608D-4494-B4BD-078319DD252EQ39020737-87594BB1-E40A-4AA8-91A9-001A110BF745Q39986425-F8D10D1E-45E3-420E-B510-91F2FF43B48CQ40945055-B3E992E7-1977-437C-8BF3-751DC6A081EFQ43118623-5DD6636D-51F8-424F-95E8-2CCFC93045C4Q44813506-E3E4FEE3-A5FC-4637-BD71-54AAB741CAF4Q44874547-94BE43DE-7F65-4CA4-8C2A-B2E0E2D9BA1BQ47962169-40000A38-4712-4757-8CE6-A4ECAA520B5BQ48833370-E9375EAE-3BBD-4243-98E1-4D443BDEE422Q51778619-42D3A5C1-E55D-4C8B-A083-26873CEF26C4Q81615839-55260395-96A7-4C31-816E-A2C636EF549AQ92855081-DC7A767E-6CC1-424A-B1DB-0A2FE4723268
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Megan Lloyd
@ast
Megan Lloyd
@en
Megan Lloyd
@es
Megan Lloyd
@nl
Megan Lloyd
@sl
type
label
Megan Lloyd
@ast
Megan Lloyd
@en
Megan Lloyd
@es
Megan Lloyd
@nl
Megan Lloyd
@sl
prefLabel
Megan Lloyd
@ast
Megan Lloyd
@en
Megan Lloyd
@es
Megan Lloyd
@nl
Megan Lloyd
@sl
P106
P1153
7102709385
P21
P31
P496
0000-0002-0140-1215